Toshihisa Nakashima

10PUBLICATIONS
13CO-AUTHORS
Disease surveillanceGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 11, 2026
Levofloxacin-associated tendon disorders: Sex-, age-, and route-specific disproportionality analysis using FAERS and JADER.

|Aug 18, 2026
Letermovir coadministration and tacrolimus concentration-to-dose ratios before and after intravenous-to-oral conversion in allogeneic hematopoietic stem cell transplant recipients receiving isavuconazole.

|Jul 29, 2026
Effectiveness of continuous pharmacist intervention at maintaining dose intensity in postoperative adjuvant S-1 chemotherapy for gastric cancer: a multicentre retrospective study.

|May 29, 2026
Current pharmacological and non-pharmacological approaches to chemotherapy-induced peripheral neuropathy and association with awareness of clinical guidelines.

|Feb 19, 2026
Clinical Determinants of Early Achievement of the Therapeutic Teicoplanin Trough Concentration Range in Adult Cancer Patients.

Toshihisa Nakashima, Osamu Kobayashi, Mika Shiotsuka

|Jun 10, 2025
The optimal conversion ratio of tacrolimus switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients receiving posaconazole prophylaxis with and without letermovir.

Toshihisa Nakashima, Azusa Kawasaki, Yoshihiro Inamoto

Pageof 2

Frequent Collaborators

2 joint publications

Yoshihiro Inamoto

1 joint publications

Sena Yamamoto

1 joint publications

Harue Arao

1 joint publications

Yoichiro Yoshida